ARF6 and AMAP1 proteins are often abnormally overexpressed in different types of cancers, including breast cancer, renal cancer, lung adenocarcinoma, head and neck cancer and PDAC, to be statistically correlated with the rapid recurrence and poor overall survival of patients [14–23]. The gene discussed is ARF6; the disease is cancer.